Sapiens Reports Third Quarter 2023 Financial Results


November 8, 2023

November 8, 2023 Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2023. 

Summary Results for Third Quarter 2023 (USD in millions, except per share data) 

  GAAP    Non-GAAP   
  Q3 2023  Q3 2022  % Change  Q3 2023  Q3 2022  % Change 
Revenue  $130.7   $119.0   9.8%   $130.8  $119.0    9.9%  
Gross Profit  $56.0  $50.3  11.3%   $59.3   $53.5  10.7%  
Gross Margin  42.8%   42.2%   60 bps  45.3%   45.0%   30 bps  
Operating Income  $20.3  $16.6  22.4%   $24.1  $20.9   15.1%  
Operating Margin  15.5%   13.9%   160 bps  18.4%   17.6%   80 bps 
Net Income (*)  $15.9   $13.4   18.5%   $19.1   $16.9  13.1%  
Diluted EPS  $0.28  $0.24   16.7%   $0.34  $0.30  13.3%  

 (*) Attributable to Sapiens’ shareholders 

Roni Al-Dor, President and CEO of Sapiens, stated, “In the third quarter, we delivered strong revenues growth, of 10% to reach $130.8 million, driven by growth in our European and North America regions.  

New logo win momentum has been strong throughout the year and existing customer product expansion has also been healthy. 

This quarter also saw further expansion in our operating margin to 18.4%, resulting in an operating profit of $24.1 million. As we have consistently done throughout 2023, we remained committed to executing our growth strategy across diverse regions and product categories. With a multitude of growth drivers at our disposal, including regional and product diversification, Sapiens is strategically positioned for both future growth and profitability.” 

 Mr. Al-Dor continued, “We are heartbroken by the war taking place in Israel, and our thoughts are with all who are impacted by these brutal terror attacks. Despite the recent tragic events in Israel, our global business has continued to run smoothly, thanks to our dedicated global employee base. During this period, we have received support from our customers, prospects, the investment community, partners, and employees.  We deeply appreciate the support during this challenging time.” 

 In commenting on the company’s outlook, Mr. Al-Dor stated, “Today, we are reiterating our 2023 full-year Non-GAAP revenue guidance of $511 – $516 million and increasing our full year 2023 Non-GAAP operating margin guidance from 18.0% – 18.2% to a range of 18.2% – 18.3%.” 

 Management will host a conference call and webcast today, November 8, 2023 at 9:30 a.m. Eastern Time (4:30 pm in Israel) to review and discuss Sapiens’ results.  

 Please call the following numbers (at least 10 minutes before the scheduled time) to participate: 

 North America (toll-free): + 1-888-642-5032; International: +972-3-918-0609; UK: 0-800-917-5108 

 The live webcast of the call can be accessed at: A replay of the call will be available one business day following the completion of the event at the same link for 90 days.

Non-GAAP Financial Measures 

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow. 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens’ financial condition and results of operations. The Company’s management uses these non-GAAP measures to compare the Company’s performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company’s financial measures with other software companies, many of which present similar non-GAAP financial measures to investors. 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments. 

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. 

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business. 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release. 

The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business. 

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business. 

About Sapiens 

Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. With more than 40 years of industry expertise, Sapiens’ cloud-based SaaS insurance platform offers pre-integrated, low-code capabilities across core, data and digital domains to accelerate our customers’ digital transformation. Serving over 600 customers in more than 30 countries, Sapiens offers insurers across property and casualty, workers’ compensation, and life insurance markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management.  For more information visit or follow us on LinkedIn. 

Investor and Media Contact 

Yaffa Cohen-Ifrah 

Chief Marketing Officer and Head of Investor Relations, Sapiens  

+1 917-533-4782 

Investor Contacts 

Kimberly Rogers
Managing Director, Hayden IR
+1 541-904-5075 

Forward Looking Statements 

Certain matters discussed in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, and are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Risk Factors” in our most recent Annual Report on Form 20-F, which we filled with the SEC on March 31, 2022, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations. 



U.S. dollars in thousands (except per share amounts)  

        Three months ended       Nine months ended 
       September 30,      September 30, 
      2023    2022    2023    2022 
       (unaudited)      (unaudited)      (unaudited)      (unaudited)  
 Revenue      130,705     118,996     383,725     355,273 
 Cost of revenue     74,753    68,721    220,080    205,415 
 Gross profit     55,952    50,275    163,645    149,858 
 Operating expenses:                  
   Research and development, net      16,028    14,804    47,391    43,405 
   Selling, marketing, general and administrative      19,659     18,919    57,475    56,443 
 Total operating expenses     35,687    33,723    104,866    99,848 
 Operating income    20,265    16,552    58,779    50,010